We are live on ! Find out more
RhumbLine Advisers

RhumbLine Advisers Portfolio holdings

AUM $117B
1-Year Est. Return 29.66%
This Fund
S&P 500
This Quarter Est. Return
+9.63%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.91%
AUM
$59.8B
AUM Growth
+$5.07B
Cap. Flow
+$518M
Cap. Flow %
0.87%
Top 10 Hldgs %
18.08%
Holding
2,992
New
38
Increased
2,358
Reduced
537
Closed
43

Top Buys

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$68M
2
TFC icon
Truist Financial
TFC
+$55.9M
3
NOW icon
ServiceNow
NOW
+$33.3M
4
UBER icon
Uber
UBER
+$21.4M
5
LVS icon
Las Vegas Sands
LVS
+$15.7M

Sector Composition

Rank Sector Weight
1 Technology 19.57%
2 Financials 15.53%
3 Healthcare 13.38%
4 Consumer Discretionary 10.07%
5 Industrials 9.99%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GILD icon
76
Gilead Sciences
GILD
$163B
$143M 0.24%
2,202,320
+28,860
+1% +$1.88M
ADP icon
77
Automatic Data Processing
ADP
$105B
$141M 0.24%
826,792
-14,250
-2% -$2.36M
UPS icon
78
United Parcel Service
UPS
$89.5B
$140M 0.23%
1,199,339
-11,317
-0.9% -$1.34M
TFC icon
79
Truist Financial
TFC
$63.5B
$140M 0.23%
2,489,721
+1,032,719
+71% +$55.9M
CAT icon
80
Caterpillar
CAT
$373B
$138M 0.23%
934,128
+3,768
+0.4% +$526K
CME icon
81
CME Group
CME
$96.1B
$138M 0.23%
685,872
-4,825
-0.7% -$990K
CHTR icon
82
Charter Communications
CHTR
$16.9B
$137M 0.23%
282,306
-10,074
-3% -$4.64M
SYK icon
83
Stryker
SYK
$133B
$135M 0.23%
642,711
-1,965
-0.3% -$408K
DUK icon
84
Duke Energy
DUK
$98.4B
$134M 0.22%
1,468,915
+55,541
+4% +$5.09M
ZTS icon
85
Zoetis
ZTS
$31.9B
$132M 0.22%
1,000,681
-2,542
-0.3% -$316K
GS icon
86
Goldman Sachs
GS
$302B
$132M 0.22%
575,965
+3,486
+0.6% +$756K
COP icon
87
ConocoPhillips
COP
$145B
$132M 0.22%
2,028,401
+1,957
+0.1% +$115K
INTU icon
88
Intuit
INTU
$86.3B
$130M 0.22%
494,811
-1,399
-0.3% -$366K
PNC icon
89
PNC Financial Services
PNC
$99.2B
$127M 0.21%
797,909
-1,743
-0.2% -$262K
D icon
90
Dominion Energy
D
$61.3B
$127M 0.21%
1,535,549
+40,847
+3% +$3.34M
ISRG icon
91
Intuitive Surgical
ISRG
$126B
$125M 0.21%
635,421
+138
+0% +$25.8K
SO icon
92
Southern Company
SO
$109B
$125M 0.21%
1,958,449
+31,974
+2% +$1.98M
TGT icon
93
Target
TGT
$65.6B
$124M 0.21%
966,209
+8,447
+0.9% +$991K
SPGI icon
94
S&P Global
SPGI
$122B
$123M 0.21%
451,191
-2,708
-0.6% -$704K
CB icon
95
Chubb
CB
$135B
$123M 0.21%
790,089
+11,902
+2% +$1.82M
BSX icon
96
Boston Scientific
BSX
$68.4B
$120M 0.2%
2,658,225
+23,480
+0.9% +$982K
FISV
97
Fiserv Inc
FISV
$28.8B
$120M 0.2%
1,038,927
+32,763
+3% +$3.62M
RTN
98
DELISTED
Raytheon Company
RTN
$119M 0.2%
542,102
+6,124
+1% +$1.29M
MU icon
99
Micron Technology
MU
$988B
$119M 0.2%
2,207,950
+236,964
+12% +$11.3M
CCI icon
100
Crown Castle
CCI
$33.4B
$117M 0.2%
824,824
+27,403
+3% +$3.74M

Similar funds

RhumbLine Advisers's Q4 2019 Portfolio in Review

As of Q4 2019, RhumbLine Advisers held 2,992 positions worth $59.8B, up 9.3% from $54.7B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Trading was light in Q4 2019: portfolio turnover was 2.7%. RhumbLine Advisers opened 38 new positions and exited 43, leaving the 2,992-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Financials and Healthcare.

  • RhumbLine Advisers's largest Q4 2019 buy was Envista: 126,664 shares worth $3.75M.
  • RhumbLine Advisers added most to Bristol-Myers Squibb in Q4 2019, an estimated $68M increase.
  • RhumbLine Advisers's biggest Q4 2019 reduction was Apple, cutting an estimated $48.3M.
  • RhumbLine Advisers fully exited Celgene Corp in Q4 2019, selling an estimated $119M.
  • RhumbLine Advisers's ten largest holdings make up 18% of its $59.8B portfolio in Q4 2019.
  • RhumbLine Advisers opened 38 new positions and closed 43 in Q4 2019.
  • RhumbLine Advisers's portfolio value rose 9.3% quarter-over-quarter to $59.8B.

Based on RhumbLine Advisers's 13F filing for Q4 2019, filed 5 Feb 2020.